This article is more than 5 years old. Information may no longer be current.
NYU Langone appoints neuro-oncology chief
Click Here to Manage Email Alerts
Andrew S. Chi, MD, PhD, has been appointed chief of neuro-oncology at NYU Langone Medical Center’s Laura and Isaac Perlmutter Cancer Center.
Chi, a physician-scientist and brain tumor specialist, also will serve as co-director of the NYU Langone Brain Tumor Center.
Andrew S. Chi
“Andrew has the drive, tenacity and passion for scientific inquiry that is needed to make the great strides against brain tumors that we hope to achieve at NYU Langone,” Benjamin G. Neel, MD, PhD, director of the Perlmutter Cancer Center at NYU Langone, said in a press release. “I look forward to working with him and expect our programs to thrive under his leadership.”
Chi will lead all neuro-oncologic related programs. He will co-lead the NYU Langone Brain Tumor Center with John G. Golfinos, MD, chair of the department of neurosurgery.
Chi joins NYU Langone from Massachusetts General Hospital, Dana-Faber/Harvard Cancer Center and Harvard Medical School, where he served as assistant professor of neurology. His clinical work at Massachusetts General Hospital included the neuro-oncologic treatment of primary brain tumors, metastatic tumors to the central nervous system and neurologic complications of cancer.
“I am thrilled to join NYU Langone and to work with Dr. Neel, Dr. Golfinos and the other respected faculty at the Perlmutter Cancer Center,” Chi said in a press release. “We share a similar vision of innovation for the cancer center, and I am confident that as a result of these efforts, we will see major scientific and clinical advances against these horrible diseases in the coming years.”